- Awad AG, Voruganti LNP, Heslegrave RJ (1995) The aims of antipsychotic medications -- What are they and are they being achieved? CNS Drugs 4: 8-16.
- Jibson MD, Tandon R (1998) New atypical antipsychotic agents. J Psychiatr Res 32: 215-8.
- Franz M, Lis S, Pluddeman K, Galhofer B (1997) Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients. Br J Psychiatry 170: 422-5.
- Bartkó G, Herczeg I, Békésy M (1987) Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement. J Clin Psychiatry 48: 363-5.
- Hogan TP, Awad AG (1992) Subjective response to neuroleptics and outcome in schizophrenia; a re-examination comparing two measures. Psychol Med 22: 347-51
- Awad AG (1993) Subjective response to neuroleptics in schizophrenia. Schizophr Bull 19: 609-18.
- Awad AG, Hogan TP, Voruganti LNP, Heslegrave RJ (1995) Patients' subjective experiences on antipsychotic medications: implications for outcome and quality of life. Int Clin Psychopharmacol 10 (suppl 3): 123-32.
- Kaiman TP (1983) An overview of pattern satisfaction with psychiatric treatment. Hasp Community Psychiatry 34: 48-54.
- Williams B (1994) Patient satisfaction: a valid concept? Soc Sd Med 38: 509-16.
- Williams B, Wilkinson G (1995) Patient satisfaction in mental health care. Evaluating an evaluative method. Br J Psychiatry 100: 559-602.
- KaIali A (1999) Patient satisfaction with, and acceptability of atypical antipsychotics. Curr Med Res Opin 15: 135-7.
- Shipley K, Hilborn B, Hansell A et al (2000) Patient satisfaction: a valid index of quality of care in a psychiatric service. Acta Psychiatr Scand 101: 330-3.
- Barker DA, Shergill SS, Higginson I et al (1996) Patients' views towards care received from psychiatrists. Br J Psychiatry 168: 641-6.
- Naber D (1995) A self-rating to measure subjective effects of neuroleptic drugs, relationship to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol 10 (suppl 3): 133-8.
- Voruganti LNP, Heslegrave RJ, Awad AG et al (1998) Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol Med 28: 165-72.
- Hogan TP, Awad AG, Eastwood MR (1983) A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative ability. Psychol Med 13: 177-83.
- Soskis DA (1978) Schizophrenic and medical inpatients as informed drug consumers. Arch Gen Psych 35: 645-9.
- Nelson A (1975) Drug defaults among schizophrenic patients. Am J Hasp Pharm 32: 1237-41
- Weiden PJ, Shaw E, Mann JJ (1986) Causes of neuroleptic noncompliance. Psychiatry Ann 16: 571-5.
- Buchanan A (1992) A two-year prospective study of treatment compliance in patients with schizophrenia. Psychol Med 22: 787-97.
- Gazer WM (1997) Clinical outcomes of pharmacotherapy for schizophrenia and implications for health economics. J Clin Psychiatry 15: 22-3.
- Keks NA (1997) Impact of newer antipsychotics on outcomes in schizophrenia. Clin Therapeut 19: 148-51
- Awad AG (1995) Quality of life issues in medicated schizophrenics: Therapeutic and research implications. In: Contemporary Issues in the Treatment of Schizophrenia (eds C Shriqui, H Nasrallah), 735-47. American Psychiatric Press, Washington, DC.
- Awad AG, Voruganti LNP, Heslegrave RJ (1997) A conceptual model of quality of life in schizophrenia: description and preliminary validation. Qual Life Res 6: 21-6.
- Hellewell JSE, Cantillon M (1998) Antipsychotic tolerability: The attitudes and perceptions of medical professionals, patients and caregivers towards the side-effects of antipsychotic therapy. Eur Neuropsychopharmacd 8 (suppl 2): S248.
- Hellewell JSE, Kalali AH, Langham SJ et al (1999) Patient satisfaction and acceptability of long-term treatment with quetiapine. Int J Psych Clin Pract 3: 105-13.
- Kopala LC, Baldwin D, Weiden PJ et al (1999) Overcoming challenges in the management of schizophrenia. Int J Psych Clin Pract 3: 11-15.
- Weiden PJ, Aquila R, Dalheim L et al (1997) Switching antipsychotic medications. J Clin Psychiatry 58 (suppl 10): 63-72.
- Masand PS, Berry SL (2000) Switching antipsychotic therapies. Ann Pharmacother 34: 200-7.
- American Psychiatric Asssociation (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, Washington DC.
- Guy W Clinical Global Impression (1976) In: ECDEU Assessment Manual for Psychopharmacology, 218-22. US Dept. of Health, Education & Welfare, Rockville, MD.
International Journal of Psychiatry in Clinical Practice
Volume 6, 2002 - Issue 1